Antimicrobial Resistance in Community-Acquired Pneumonia: A Study on Syrian Patients Reveals Serious Health Challenges
Antimicrobial resistance is one of the most prominent global health challenges threatening healthcare systems in many countries, particularly in developing nations like Syria. This phenomenon leads to increased rates of infection and mortality, especially those associated with Community-Acquired Pneumonia (CAP), a disease that significantly impacts the health of populations in conflict zones.
In this context, a research team from the Faculty of Pharmacy at the International University for Science and Technology, in collaboration with experts from the World Health Organization, conducted a scientific study titled “Study of pathogens causing community-acquired pneumonia and antibiotic resistance patterns in Syrian patients.”
This study aimed to identify the main types of bacteria causing community-acquired pneumonia in Syria, in addition to assessing the resistance rates of these bacteria to recommended antibiotics.
The study was conducted at Ibn Al-Nafis Hospital in Damascus, involving 100 cases representing a group of patients who visited the chest diseases department between September 2022 and March 2023.
The results revealed three main types of bacteria responsible for about three-quarters of community-acquired pneumonia cases:
Streptococcus pneumoniae* (41%)
Staphylococcus aureus* (16%)
Klebsiella* species (14%)
These results indicate that community-acquired pneumonia in Syria is primarily caused by these bacterial types, highlighting the necessity for continuous research into these microbes and the development of effective treatment strategies.
The study also showed high levels of resistance among the bacteria to antibiotics typically recommended for treating community-acquired pneumonia, complicating treatment and management of these cases. Notably, resistance rates in Gram-negative bacteria (like Klebsiella) were significantly higher compared to Gram-positive bacteria (like *Streptococcus pneumoniae*).
Results indicated that Gram-negative bacteria were most resistant to antibiotics such as Nitrofurantoin, Cefazolin, and Cefoxitin, with resistance rates reaching 100%, 91.7%, and 91.3% respectively.
Meanwhile, Gram-positive bacteria showed higher resistance to Erythromycin, Cefoxitin, and Oxacillin, with Erythromycin resistance at 91.37%, Cefoxitin at 91.22%, and Oxacillin at 87.71%.
On the other hand, Gram-positive bacteria, like Streptococcus pneumoniae, showed higher susceptibility to other antibiotics such as Cefotaxime (71%) and Ceftriaxone (81%), emphasizing the importance of selecting optimal treatment based on laboratory testing.
This study is considered a significant step towards a deeper understanding of the reality of antibiotic resistance in Syria and confirms the necessity of adapting global recommendations for treating community-acquired pneumonia based on the local context.
The study also recommends the necessity of continuous monitoring of local antibiotic resistance rates, developing adequately equipped laboratories, in addition to the importance of training doctors and infectious disease specialists within hospitals to make accurate and effective therapeutic decisions.
The results of this study indicate that antimicrobial resistance poses a growing health challenge in Syria, requiring a locally-informed response grounded in data and ongoing research. The study also highlights the importance of collaboration between academic and health institutions and global bodies like the World Health Organization to address this escalating health crisis.
It is worth noting that the study was published in the Italian journal *The Journal of Infection in Developing Countries*, classified in the Scopus database as Q3 in the Spring.